These molecular changes segregate with the distinct histological subgroups of glioma: for example, most of the diffuse astrocytoma have TP53 and IDH1/2 mutation and most of the oligodendrogliomas have LOH 1p19q and IDH1/2 mutation. Here, IDH1 is linked to oligodendroglioma.